Gap’s 2Q Profits Fall, Reflecting Chain Still Mired in Slump
Gap’s 2Q profits fall 43%, chain continues to be mired in sales slump.
All Posts in "News Team"
Why Streaming Services Are the New Credit Card Rewards Binge
Here’s why credit card issuers are betting big on streaming services, allowing you to earn bonus rewards as you binge-watch.
US Stock Indexes End Mixed Ahead of Fed Chairman Speech
A wobbly day on Wall Street left stock indexes mostly lower Thursday as investors turned cautious ahead of a widely anticipated speech by the Federal Reserve chairman.
Report Shows US Deficit to Exceed $1 Trillion Next Year
The Congressional Budget Office says the federal budget deficit is expected to balloon to more than $1 trillion in the next fiscal year.
Gold retreats as the U.S. stock market strengthens, traders await Fed minutes for clues on interest rates
Fed will publish minutes of July 30-31 meeting at 2 p.m. ET
Europe stocks edge lower as Fed looks hesitant
European stocks drifted lower on Thursday, after indications that the U.S. Federal Reserve last month wasn’t aggressively looking to cut interest rates in the world’s largest economy.
Here’s what bitcoin’s relationship with the stock market and gold looks like over the past 90 days
Bitcoin starting correlate with gold, stocks
Dow books 240-point gain as bond-market recession signal flashes after Fed minutes
Retailers’ quarterly results offer more evidence of consumer strength
Equities Analysts Set Expectations for Allena Pharmaceuticals Inc’s FY2023 Earnings (NASDAQ:ALNA)
Allena Pharmaceuticals Inc (NASDAQ:ALNA) – Equities researchers at B. Riley issued their FY2023 earnings estimates for Allena Pharmaceuticals in a research report issued to clients and investors on Friday, July 26th, according to Zacks Investment Research. B. Riley analyst M. Mamtani expects that the company will post earnings per share of ($0.37) for the year.
Equities Analysts Decrease Earnings Estimates for Brink’s (NYSE:BCO)
Brink’s (NYSE:BCO) – Analysts at Imperial Capital cut their FY2019 earnings estimates for Brink’s in a research report issued on Thursday, July 25th, according to Zacks Investment Research. Imperial Capital analyst J. Kessler now expects that the business services provider will post earnings per share of $4.27 for the year, down from their prior forecast of $4.30. Imperial Capital currently has a “Outperform” rating and a $105.00 target price on the stock. Imperial Capital also issued estimates for Brink’s’ Q4 2019 earnings at $1.56 EPS, Q1 2020 earnings at $1.00 EPS, Q2 2020 earnings at $1.02 EPS, Q3 2020 earnings at $1.37 EPS and FY2020 earnings at $5.09 EPS.
Weekly Market Review – May 4, 2024
FDA accepts first AI algorithm to drug development tool pilot, with Deliberate AI’s anxiety and depression assessment
Google captures FDA de novo clearance for Pixel smartphone thermometer app
Neuralink fined for violating hazardous material transport rules, docs show: Reuters
Element Science’s slim cardioverter defibrillator patch claims European approval
Week of IPO success stories suggest biotech has reached ‘recovery phase’ in 2024
Formosa, fresh from Eyenovia deal, sells Brazilian rights to near-approval eye drug
Minoryx, clutching data from failed trial, knocked back by EMA but vows to seek rerun of review
ArriVent takes in $175M from second biotech IPO of the year
Silo Pharma’s ketamine-based drug for Alzheimer’s effective against dementia symptoms in mice